Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 9
2003 8
2004 9
2005 8
2006 7
2007 10
2008 7
2009 3
2010 3
2011 6
2012 7
2013 11
2014 9
2015 5
2016 5
2017 6
2018 4
2019 1
2020 2
2021 4
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Biosimilars - terms of use.
Declerck P, Mellstedt H, Danese S. Declerck P, et al. Among authors: mellstedt h. Curr Med Res Opin. 2015 Dec;31(12):2325-30. doi: 10.1185/03007995.2015.1098601. Epub 2015 Oct 27. Curr Med Res Opin. 2015. PMID: 26397731 Review.
European Perspective on Biosimilars.
Mellstedt H. Mellstedt H. J Oncol Pract. 2017 Sep;13(9_suppl):15s-16s. doi: 10.1200/JOP.2017.025569. J Oncol Pract. 2017. PMID: 28898594 No abstract available.
Therapeutic vaccines for cancer: an overview of clinical trials.
Melero I, Gaudernack G, Gerritsen W, Huber C, Parmiani G, Scholl S, Thatcher N, Wagstaff J, Zielinski C, Faulkner I, Mellstedt H. Melero I, et al. Among authors: mellstedt h. Nat Rev Clin Oncol. 2014 Sep;11(9):509-24. doi: 10.1038/nrclinonc.2014.111. Epub 2014 Jul 8. Nat Rev Clin Oncol. 2014. PMID: 25001465 Review.
Ibrutinib-A double-edge sword in cancer and autoimmune disorders.
Kokhaei P, Jadidi-Niaragh F, Sotoodeh Jahromi A, Osterborg A, Mellstedt H, Hojjat-Farsangi M. Kokhaei P, et al. Among authors: mellstedt h. J Drug Target. 2016;24(5):373-85. doi: 10.3109/1061186X.2015.1086357. Epub 2015 Sep 11. J Drug Target. 2016. PMID: 26362595 Review.
A Small Molecule Targeting the Intracellular Tyrosine Kinase Domain of ROR1 (KAN0441571C) Induced Significant Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells.
Ghaderi A, Okhovat MA, Lehto J, De Petris L, Manouchehri Doulabi E, Kokhaei P, Zhong W, Rassidakis GZ, Drakos E, Moshfegh A, Schultz J, Olin T, Österborg A, Mellstedt H, Hojjat-Farsangi M. Ghaderi A, et al. Among authors: mellstedt h. Pharmaceutics. 2023 Apr 5;15(4):1148. doi: 10.3390/pharmaceutics15041148. Pharmaceutics. 2023. PMID: 37111634 Free PMC article.
Strategies in the management of alemtuzumab-related side effects.
Osterborg A, Karlsson C, Lundin J, Kimby E, Mellstedt H. Osterborg A, et al. Among authors: mellstedt h. Semin Oncol. 2006 Apr;33(2 Suppl 5):S29-35. doi: 10.1053/j.seminoncol.2006.01.027. Semin Oncol. 2006. PMID: 16720201 Review.
109 results